Vifor Fresenius Medical Care Renal Pharma

Clinical trials sponsored by Vifor Fresenius Medical Care Renal Pharma, explained in plain language.

Now part of Fresenius Medical Care AG FMS NYSE

Renal pharmaceutical company, a joint venture of Fresenius Medical Care and Vifor Pharma.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 1 Not yet finished but already full! 1 Completed 2

New hope for teens on dialysis: drug targets severe itching

Symptom relief Recruiting now

This study tests a medicine called difelikefalin in teenagers aged 12 to 17 who are on hemodialysis and have moderate to severe itching. The goal is to see if the drug is safe and how much gets into the blood. About 18 teens will receive the medicine up to 4 times a week for 12 w…

Phase 2 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Symptom relief

Last updated Sep 03, 2026 00:00 UTC

Vifor Fresenius Medical Care Renal Pharma

New hope for teens on dialysis: drug targets severe itching